Release 4 FHIR CI-Build

This page is part of the Continuous Integration Build of FHIR Specification (v4.0.1: R4 - Mixed Normative and STU ) in it's permanent home (it will always (will be available incorrect/inconsistent at this URL). The current version which supercedes this version is 5.0.0 . For a full list of available versions, see times).
See the Directory of published versions . Page versions: R5 R4B R4 R3

Medicationdispense0306

Example MedicationDispense/meddisp0306 (Narrative)

Maturity Level : N/A
Responsible Owner: Pharmacy Work Group Standards Status : Informative Compartments : Encounter , Group , Patient , Practitioner

This is the narrative for the resource. See also the XML , JSON or Turtle format. This example conforms to the profile MedicationDispense .

Generated Narrative with Details Narrative: MedicationDispense meddisp0306

id : meddisp0306

contained status : In Progress

Medications

status : in-progress
- medication : Alemtuzumab 10mg/ml (Lemtrada). Generated Summary: id: med0303; Alemtuzumab 10mg/ml (Lemtrada) (Details : {RxNorm code '1594660' = 'alemtuzumab Reference
* alemtuzumab 10 MG/ML [Lemtrada]', given as 'Alemtuzumab 10mg/ml (Lemtrada)'}) [Lemtrada]

subject : Donald Duck

Performers

- Actor
* Practitioner/f006 Practitioner Rob van den Berk (official)

authorizingPrescription : MedicationRequest/medrx0317 MedicationRequest: identifier = http://www.bmc.nl/portal/prescriptions#12345689 (use: official, ); status = completed; intent = order; authoredOn = 2015-01-15

type : Daily Fill (Details : {http://terminology.hl7.org/CodeSystem/v3-ActCode code 'DF' = 'Daily Fill', given as 'Daily Fill'})

quantity : 5 5(unit 415818006 from http://snomed.info/sct) (Details: SNOMED CT code 415818006 code415818006 = 'Vial')

daysSupply : 7 Day (Details: UCUM code d coded = 'd')

whenPrepared : 15/01/2015 10:20:00 AM 2015-01-15T10:20:00Z

dosageInstruction

step

component

text : Rapid daily-dose escalation, until tolerated, from 3 mg/d, and then 10 mg/d, to the recommended maintenance dose of 30 mg IV over 120 min, 3 times per wk on alternate days for up to 12 wk

additionalInstruction : Rapidly increase dose until tolerated , Administer on alternate days

timing : Duration 12weeks , 3 per 1 week

route : Intravenous route

method : Inject - dosing instruction imperative (qualifier value)

DoseAndRates

- Type Dose[x]
* Calculated 3 mg (Details: UCUM codemg = 'mg')

step

component

text : Rapid daily-dose escalation, until tolerated, from 3 mg/d, and then 10 mg/d, to the recommended maintenance dose of 30 mg IV over 120 min, 3 times per wk on alternate days for up to 12 wk

additionalInstruction : Rapidly increase dose until tolerated , Administer on alternate days

timing : Duration 12weeks , 3 per 1 week

route : Intravenous route

method : Inject - dosing instruction imperative (qualifier value)

DoseAndRates

- Type Dose[x]
* Calculated 10 mg (Details: UCUM codemg = 'mg')

step

component

text : Rapid daily-dose escalation, until tolerated, from 3 mg/d, and then 10 mg/d, to the recommended maintenance dose of 30 mg IV over 120 min, 3 times per wk on alternate days for up to 12 wk

additionalInstruction : Rapidly increase dose until tolerated , Administer on alternate days

timing : Duration 12weeks , 3 per 1 week

route : Intravenous route

method : Inject - dosing instruction imperative (qualifier value)

DoseAndRates

- Type Dose[x]
* Calculated 30 mg (Details: UCUM codemg = 'mg')

Generated Narrative: Medication #med0303

code : alemtuzumab 10 MG/ML [Lemtrada]

 

 

Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.